NCT06920628View on ClinicalTrials.gov

PET Imaging of Cyclooxygenase-1 in Participants With Neurological Manifestations of Post-Acute Sequelae of SARS-CoV-2 Infection (PASC)

PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 18, 2025

Primary Completion Date

February 22, 2028

Study Completion Date

February 22, 2029

Conditions
Long COVIDPost Acute Sequelae of COVID-19
Interventions
DRUG

11C-PS13

Injected IV followed by PET scanning.

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Mental Health (NIMH)

NIH